Pfizer mothballs Hep B shot as competition jabs
Pfizer India has decided to withdraw its hepatitis B vaccine, Hepashield, from the market. The decision signals the beginning of a shakeout in the hepatitis B segment, which sometime sago commanded
Pfizer India has decided to withdraw its hepatitis B vaccine, Hepashield, from the market. The decision signals the beginning of a shakeout in the hepatitis B segment, which sometime sago commanded